End-of-Life Discussions, Goal Attainment, and Distress at the End of Life: Predictors and Outcomes of Receipt of Care Consistent With Preferences

Abstract

A B S T R A C T PurposePhysicians have an ethical obligation to honor patients' values for care, including at the end of life (EOL). We sought to evaluate factors that help patients to receive care consistent with their preferences. MethodsThis was a longitudinal multi-institutional cohort study. We measured baseline preferences for life-extending versus symptom-directed care and actual EOL care received in 325 patients with advanced cancer. We also measured associated sociodemographic, health, and communication characteristics, including EOL discussions between patients and physicians. ResultsPreferences were assessed a median of 125 days before death. Overall, 68% of patients (220 of 325 patients) received EOL care consistent with baseline preferences. The proportion was slightly higher among patients who recognized they were terminally ill (74%, 90 of 121 patients; P ϭ .05). Patients who recognized their terminal illness were more likely to prefer symptom-directed care (83%, 100 of 121 patients; v 66%, 127 of 191 patients; P ϭ .003). However, some patients who were aware they were terminally ill wished to receive life-extending care (17%, 21 of 121 patients). Patients who reported having discussed their wishes for EOL care with a physician (39%, 125 of 322 patients) were more likely to receive care that was consistent with their preferences, both in the full sample (odds ratio [OR] ϭ 2.26; P Ͻ .0001) and among patients who were aware they were terminally ill (OR ϭ 3.94; P ϭ .0005). Among patients who received no life-extending measures, physical distress was lower (mean score, 3.1 v 4.1; P ϭ .03) among patients for whom such care was consistent with preferences. ConclusionPatients with cancer are more likely to receive EOL care that is consistent with their preferences when they have had the opportunity to discuss their wishes for EOL care with a physician.

Discontinuing Bevacizumab in Patients with Glioblastoma: An Ethical Analysis

“…In addition, for some patients, continuing bevacizumab may provide psychological benefits. Mack et al [18] recently showed that a minority of patients with advanced cancer desired attempts at life-extending therapy, even after recognizing the terminal nature of their disease. Although this subgroup of patients did not succeed in prolonging their lives, the authors note that some patients may nonetheless want assurance that they did "everything possible" to extend life.…”

Communicating About Prognosis: Ethical Responsibilities of Pediatricians and Parents

“…In fact, patients who recognize a poor prognosis are more likely to receive the care they want (whether intensive life-prolonging care or care focused on symptoms) at the end of life. 29 Conversations about prognosis thus support patient autonomy and value-driven decision-making, not just 1 kind of care.…”

A National Survey to Systematically Identify Factors Associated With Oncologists’ Attitudes Toward End-of-Life Discussions: What Determines Timing of End-of-Life Discussions?

“…Having timely end-of-life discussions (EOLds) with advanced cancer patients is essential; multiple empirical studies demonstrate that EOLds reduce unnecessary aggressive care near death, provide end-of-life (EOL) care consistent with patients' preferences, increase early hospice referrals, and improve patients' quality of life [1][2][3][4][5]. Many physicians, however, do not actually discuss EOL options with advanced cancer patients until they are in the terminal phase of life [6,7].…”